tryptophan has been researched along with ketamine in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 4 (26.67) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Allegri, G; Ambrosio, F; Baron, P; Ceccherelli, F; Costa, C; De Antoni, A; Manani, G; Vanzan, S | 1 |
| Martin, LL; Smith, DJ | 1 |
| Buck, DP; Clements, JD; Howitt, SM | 1 |
| Gilles, C; Luthringer, R | 1 |
| Fukushima, T; Haruta, N; Ichiba, H; Iizuka, H; Ishii, K; Yoshihara, S | 1 |
| Hashimoto, K; Shi, JY; Wang, N; Yang, C; Yang, JJ; Yu, HY | 1 |
| Guo, J; Han, JF; Pan, W; Sun, KJ; Wang, J; Xie, ZM; Yang, JJ; Zhang, GF | 1 |
| Bottrel, N; Corum, DG; Drevets, WC; Fiehn, O; Kaddurah-Daouk, R; Motsinger-Reif, A; Rotroff, DM; Salvadore, G; Singh, J | 1 |
| Cordeiro, RC; da Silva Araújo, T; de Freitas Lima, R; de Jesus Souza Machado, M; Freitas de Lucena, D; Isabelle de Góis Queiroz, A; Macêdo, D; Maes, M; Maia Chaves Filho, AJ; Monte, AS | 1 |
| Chen, L; Li, H; Li, M; Liu, W; Ning, Y; Wang, C; Zhan, Y; Zheng, W; Zhou, Y | 1 |
| Fan, N; Lu, H; Luo, Y; Ni, X; Wen, Y; Zhang, M; Zhang, Z | 1 |
| Kopra, E; Mondelli, V; Nikkheslat, N; Pariante, C | 1 |
| Cubała, WJ; Gruchała-Niedoszytko, M; Małgorzewicz, S; Mechlińska, A; Włodarczyk, A | 1 |
| Andrade, C | 1 |
3 review(s) available for tryptophan and ketamine
| Article | Year |
|---|---|
Pharmacological models in healthy volunteers: their use in the clinical development of psychotropic drugs.
Topics: Apomorphine; Cognition Disorders; Dopamine Agonists; Excitatory Amino Acid Antagonists; GABA Modulators; Humans; Ketamine; Lorazepam; Memory Disorders; Models, Psychological; Muscarinic Antagonists; Panic Disorder; Psychotropic Drugs; Scopolamine; Tryptophan | 2007 |
Ketamine's effect on inflammation and kynurenine pathway in depression: A systematic review.
Topics: Animals; Anti-Inflammatory Agents; Antidepressive Agents; Bipolar Disorder; Cytokines; Depressive Disorder, Major; Humans; Inflammation; Ketamine; Kynurenine; Tryptophan | 2021 |
Reconsideration of the Benefits of Pharmacological Interventions for the Attenuation of the Cognitive Adverse Effects of Electroconvulsive Therapy.
Topics: Calcium Channel Blockers; Cholinesterase Inhibitors; Cognition; Electroconvulsive Therapy; Humans; Hydrocortisone; Ketamine; Melatonin; Memantine; Narcotic Antagonists; Nortriptyline; Pemoline; Piracetam; Treatment Outcome; Triiodothyronine; Tryptophan | 2022 |
12 other study(ies) available for tryptophan and ketamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The influence of acupuncture on blood serum levels of tryptophan in healthy volunteers subjected to ketamine anesthesia.
Topics: Acupuncture Therapy; Adult; Anesthesia, General; Brain; Humans; Ketamine; Male; Serotonin; Tryptophan | 1982 |
Ketamine inhibits serotonin synthesis and metabolism in vivo.
Topics: Animals; Brain; Depression, Chemical; Hydroxyindoleacetic Acid; Ketamine; Male; Neurons; Rats; Rats, Inbred Strains; Serotonin; Synaptosomes; Time Factors; Tryptophan | 1982 |
NMDA channel gating is influenced by a tryptophan residue in the M2 domain but calcium permeation is not altered.
Topics: Animals; Biophysical Phenomena; Biophysics; Calcium; Cell Line; Dizocilpine Maleate; Humans; Ion Channel Gating; Ketamine; Magnesium; Mice; Mutagenesis, Site-Directed; Permeability; Protein Structure, Tertiary; Receptors, N-Methyl-D-Aspartate; Recombinant Proteins; Tryptophan | 2000 |
Alteration in the plasma concentration of a DAAO inhibitor, 3-methylpyrazole-5-carboxylic acid, in the ketamine-treated rats and the influence on the pharmacokinetics of plasma D-tryptophan.
Topics: Animals; Chromatography, High Pressure Liquid; D-Amino-Acid Oxidase; Enzyme Inhibitors; Ketamine; Male; Mass Spectrometry; Pyrazoles; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tryptophan | 2011 |
Serum interleukin-6 is a predictive biomarker for ketamine's antidepressant effect in treatment-resistant patients with major depression.
Topics: Antidepressive Agents; Biomarkers, Pharmacological; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Humans; Inpatients; Interleukin-1beta; Interleukin-6; Ketamine; Kynurenine; Psychiatric Status Rating Scales; Treatment Outcome; Tryptophan; Tumor Necrosis Factor-alpha | 2015 |
Acute single dose of ketamine relieves mechanical allodynia and consequent depression-like behaviors in a rat model.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Freund's Adjuvant; Hippocampus; Hyperalgesia; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inflammation; Interleukin-1beta; Interleukin-6; Ketamine; Kynurenine; Male; Nociception; Rats; Rats, Sprague-Dawley; Serotonin; Tryptophan | 2016 |
Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants.
Topics: Adult; Arginine; Citrulline; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Humans; Indoleacetic Acids; Infusions, Intravenous; Ketamine; Male; Metabolomics; Methionine; Middle Aged; Ornithine; Phenotype; Phospholipids; Tryptophan; Urea | 2016 |
Reversal of schizophrenia-like symptoms and immune alterations in mice by immunomodulatory drugs.
Topics: Animals; Antipsychotic Agents; Brain; Disease Models, Animal; Immunologic Factors; Immunomodulation; Interleukin-4; Interleukin-6; Ketamine; Male; Melatonin; Mice; Neuroimmunomodulation; Random Allocation; Risperidone; Schizophrenia; Schizophrenic Psychology; Tryptophan | 2017 |
Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression.
Topics: Administration, Intravenous; Adult; Antidepressive Agents; Bipolar Disorder; China; Chromatography, Liquid; Depression; Depressive Disorder; Female; Humans; Ketamine; Kynurenic Acid; Kynurenine; Male; Tandem Mass Spectrometry; Tryptophan | 2018 |
Preliminary comparative analysis of kynurenine pathway metabolites in chronic ketamine users, schizophrenic patients, and healthy controls.
Topics: Adult; Case-Control Studies; Chromatography, High Pressure Liquid; Female; Humans; Ketamine; Kynurenic Acid; Kynurenine; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Substance-Related Disorders; Tandem Mass Spectrometry; Time Factors; Tryptophan; Young Adult | 2020 |
Dietary Patterns of Treatment-Resistant Depression Patients.
Topics: Depression; Dietary Fats; Fatty Acids, Monounsaturated; Fatty Acids, Unsaturated; Humans; Ketamine; Tryptophan; Vitamins | 2022 |